Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Aggressive Subcutaneous Panniculitis-Like CD30+ Peripheral T-Cell Lymphoma with Diffuse EBER Expression.

Aneja A, LevakaVeera R, Patel V, Bains A.

Case Rep Hematol. 2014;2014:874725. doi: 10.1155/2014/874725. Epub 2014 Jul 20.

2.

Pericardial involvement as an initial presentation of anaplastic large cell lymphoma.

Muthusamy P, Ebrom S, Cohle SD, Khan N.

Can Fam Physician. 2014 Jul;60(7):638-41. No abstract available.

3.

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.

Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3.

4.

MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.

Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, Bhagavathi S, Greiner TC, Weisenburger DD, Aoun P, Perkins SL, McKeithan TW, Inghirami G, Chan WC.

Blood. 2013 Sep 19;122(12):2083-92. doi: 10.1182/blood-2012-08-447375. Epub 2013 Jun 25.

5.

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.

Bisig B, de Reyni├Ęs A, Bonnet C, Sujobert P, Rickman DS, Marafioti T, Delsol G, Lamant L, Gaulard P, de Leval L.

Haematologica. 2013 Aug;98(8):1250-8. doi: 10.3324/haematol.2012.081935. Epub 2013 May 28.

6.

An update on the management of peripheral T-cell lymphoma and emerging treatment options.

Phillips AA, Owens C, Lee S, Bhagat G.

J Blood Med. 2011;2:119-29. doi: 10.2147/JBM.S8627. Epub 2011 Sep 12.

7.

Pathobiology of ALK-negative anaplastic large cell lymphoma.

Pileri SA, Agostinelli C, Bacci F, Sabattini E, Sagramoso C, Falini B, Piccaluga PP.

Pediatr Rep. 2011 Jun 22;3 Suppl 2:e5. doi: 10.4081/pr.2011.s2.e5.

8.

Pathobiology of anaplastic large cell lymphoma.

Piccaluga PP, Gazzola A, Mannu C, Agostinelli C, Bacci F, Sabattini E, Sagramoso C, Piva R, Roncolato F, Inghirami G, Pileri SA.

Adv Hematol. 2010:345053. doi: 10.1155/2010/345053. Epub 2011 Feb 6.

9.

Epstein-Barr virus positive anaplastic large cell lymphoma: myth or reality?

Ma L, Katz Y, Sharan KP, Schwarting R, Kim AS.

Int J Clin Exp Pathol. 2010 Nov 20;4(1):100-10.

10.

A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

Kretzer NM, Cherian MT, Mao C, Aninye IO, Reynolds PD, Schiff R, Hergenrother PJ, Nordeen SK, Wilson EM, Shapiro DJ.

J Biol Chem. 2010 Dec 31;285(53):41863-73. doi: 10.1074/jbc.M110.183723. Epub 2010 Nov 1.

11.

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.

Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL, Kurtin PJ, Dogan A.

Leukemia. 2009 Mar;23(3):574-80. doi: 10.1038/leu.2008.320. Epub 2008 Nov 6.

12.

Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study.

Hutchison RE, Laver JH, Chang M, Muzzafar T, Desai S, Murphy S, Schwenn M, Shuster J, Link MP; Children's Oncology Group..

Pediatr Blood Cancer. 2008 Jul;51(1):29-33. doi: 10.1002/pbc.21543.

13.

Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.

Park SR, Baek JY, Kim DW, Im SA, Kim TY, Bang YJ, Kim NK, Jeon YK, Kim CW, Heo DS.

J Korean Med Sci. 2006 Aug;21(4):633-8.

Supplemental Content

Support Center